He was a visiting professor at the Harvard-MIT Division of Health Sciences and Technologies, at the Brigham Women's Hospital of the Harvard Medical School, in Cambridge Massachusetts (2014-2017).
[1] He continued his education studying a masters and doctorate in chemical and biochemical engineering at Rutgers University in the research group of Professor Fernando Muzzio, and post-doctoral work at Bristol Myers Squibb in the United States under the supervision of Dr. San Kiang.
[3] Later, Álvarez's group became involved in the design and fabrication of Chips capable to produce monoclonal antibodies through anchorage dependent mammalian cell culture.
The Álvarez-Trujillo Laboratory (https://alvareztrujillolab.com/) is today one of the most productive Tissue Engineering Laboratories in Latin America and hosts the activity of postdoctoral researchers, graduate students, and undergraduate volunteers that are trained in state of the art techniques while publishing in high-impact international journals.
He has been cited more than 6,000 times in scientific publications including Nature, PNAS, and Physical Review Letters.